Our facilities
Biocodex operates three manufacturing facilities in France and Morocco in compliance with the highest standards to guarantee product quality and safety.
Biocodex’s state-of-the-art manufacturing and logistics center in Beauvais, France
Biocodex has operated a 9-hectare manufacturing and logistics center in Beauvais, near Paris, since 1968.
Initially focused on manufacturing Biocodex’s Saccharomyces boulardii CNCM I-745® probiotic yeast, the plant has been progressively upgraded to meet growing demand as the company has expanded. Since 2005, Biocodex has accelerated this process, investing in state-of-the-art equipment and technologies. In 2017, Biocodex reached an important milestone with the installation of one of the pharmaceutical industry’s largest lyophilization platforms worldwide, for Saccharomyces boulardii CNCM I-745®. This extension was a real technical feat as it was held without interrupting a single day production.
This platform houses around
- 30 pieces of equipment,
- Two 15,000-liter bioreactors,
- One centrifugal separator and
- Two 55 m² freeze dryers.
Biocodex industrial facility
Learn more with this 2:44 minutes video about Biocodex’s plant certified Good Manufacturing Practices (GMP) guaranteeing the best product quality worldwide.
Biocodex’s Good Manufacturing Practices Certifications
The Beauvais factory controls the entire drug production process from manufacturing to shipping. Depending on the product, our facility may produce the active pharmaceutical ingredient and/or package the final product. In all cases, Beauvais is at the heart of our quality system, complying with Good Manufacturing Practices (GMP) as certified by France’s National Agency for the Safety of Medicines and Health Products (ANSM), the United States Food and Drug Administration (USFDA) and other national authorities worldwide.
Beauvais Key figures
- More than 200 employees
- 6,000 m2 logistics hub
- 100 million boxes shipped every year
- 96% on-time delivery
- Shipping to more than 100 countries
Biocodex plant in Casablanca, Morocco
Biocodex has operated a 1-hectare plant in Nouaceur, near Casablanca, since 2012. This facility focuses on manufacturing Biocodex products in liquid form.
The Casablanca factory controls the entire drug production process from manufacturing to distribution and quality control, complying with Moroccan and European Good Manufacturing Practices (GMP).
Casablanca plant key figures
- 40 million vials per year
- 2 production lines
- 50 highly qualified operators
Ferlux plant, France
Acquired by Biocodex in 2014, the Ferlux plant near Clermont-Ferrand specializes in the manufacture of API Catocyanic Complex, an extract of wild bilberries (Vaccinium myrtillus), used in pharmaceutical applications for Difrarel range. Using gentle extraction and purification processes, Ferlux guarantees optimum quality while adapting to climatic and natural variations in the raw material. The plant is GMP-certified. In April 2024, it was inspected by the ANSM, this inspection was successfully completed.
2024 marks the 10th anniversary of the Ferlux industrial site, a key player in the production of polyphenol-rich fruit extracts.
